JP2015187157A5 - - Google Patents

Download PDF

Info

Publication number
JP2015187157A5
JP2015187157A5 JP2015126043A JP2015126043A JP2015187157A5 JP 2015187157 A5 JP2015187157 A5 JP 2015187157A5 JP 2015126043 A JP2015126043 A JP 2015126043A JP 2015126043 A JP2015126043 A JP 2015126043A JP 2015187157 A5 JP2015187157 A5 JP 2015187157A5
Authority
JP
Japan
Prior art keywords
administration
medicament
period
days
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015126043A
Other languages
English (en)
Japanese (ja)
Other versions
JP6153967B2 (ja
JP2015187157A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015187157A publication Critical patent/JP2015187157A/ja
Publication of JP2015187157A5 publication Critical patent/JP2015187157A5/ja
Application granted granted Critical
Publication of JP6153967B2 publication Critical patent/JP6153967B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2015126043A 2004-04-30 2015-06-23 延長されたホルモン避妊法における破綻出血の管理 Expired - Lifetime JP6153967B2 (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US56644304P 2004-04-30 2004-04-30
US60/566,443 2004-04-30
US57502404P 2004-05-28 2004-05-28
US60/575,024 2004-05-28
US57719904P 2004-06-07 2004-06-07
US60/577,199 2004-06-07
US63838004P 2004-12-27 2004-12-27
US60/638,380 2004-12-27
US66006805P 2005-03-10 2005-03-10
US60/660,068 2005-03-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012227416A Division JP6134491B2 (ja) 2004-04-30 2012-10-12 延長されたホルモン避妊法における破綻出血の管理

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016241318A Division JP2017048253A (ja) 2004-04-30 2016-12-13 延長されたホルモン避妊法における破綻出血の管理

Publications (3)

Publication Number Publication Date
JP2015187157A JP2015187157A (ja) 2015-10-29
JP2015187157A5 true JP2015187157A5 (enExample) 2016-07-07
JP6153967B2 JP6153967B2 (ja) 2017-06-28

Family

ID=35056905

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007509994A Withdrawn JP2007535519A (ja) 2004-04-30 2005-04-29 延長されたホルモン避妊法における破綻出血の管理
JP2012227416A Expired - Lifetime JP6134491B2 (ja) 2004-04-30 2012-10-12 延長されたホルモン避妊法における破綻出血の管理
JP2015126043A Expired - Lifetime JP6153967B2 (ja) 2004-04-30 2015-06-23 延長されたホルモン避妊法における破綻出血の管理
JP2016241318A Withdrawn JP2017048253A (ja) 2004-04-30 2016-12-13 延長されたホルモン避妊法における破綻出血の管理

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2007509994A Withdrawn JP2007535519A (ja) 2004-04-30 2005-04-29 延長されたホルモン避妊法における破綻出血の管理
JP2012227416A Expired - Lifetime JP6134491B2 (ja) 2004-04-30 2012-10-12 延長されたホルモン避妊法における破綻出血の管理

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016241318A Withdrawn JP2017048253A (ja) 2004-04-30 2016-12-13 延長されたホルモン避妊法における破綻出血の管理

Country Status (29)

Country Link
US (3) US8163721B2 (enExample)
EP (1) EP1747001B1 (enExample)
JP (4) JP2007535519A (enExample)
KR (4) KR20160150113A (enExample)
CN (1) CN103127156A (enExample)
AR (1) AR048722A1 (enExample)
AU (1) AU2005237255B2 (enExample)
BR (1) BRPI0510493A (enExample)
CA (1) CA2562296A1 (enExample)
CR (1) CR8709A (enExample)
DK (1) DK1747001T3 (enExample)
EA (2) EA016625B1 (enExample)
EC (1) ECSP066999A (enExample)
ES (1) ES2704999T3 (enExample)
HU (1) HUE041475T2 (enExample)
IL (1) IL178458A (enExample)
LT (1) LT1747001T (enExample)
MX (1) MXPA06012567A (enExample)
MY (1) MY151322A (enExample)
NO (1) NO341685B1 (enExample)
NZ (1) NZ586107A (enExample)
PA (1) PA8631801A1 (enExample)
PE (1) PE20060467A1 (enExample)
SG (2) SG10201701904TA (enExample)
SI (1) SI1747001T1 (enExample)
SV (1) SV2006002100A (enExample)
TW (1) TWI374735B (enExample)
UY (1) UY28875A1 (enExample)
WO (1) WO2005105103A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US20070088010A1 (en) * 2005-10-17 2007-04-19 Doris Huebler Method of making a single-stage pharmaceutical preparation for oral therapy of dysfunctional uterine bleeding, containing ethinyl estradiol and dienogest
EP1977752A1 (de) * 2007-03-01 2008-10-08 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Zubereitung zur Verminderung der Endometriose
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
CA2736707A1 (en) * 2008-09-16 2010-03-25 Playtex Products, Llc Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
US9198919B2 (en) 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
CA2740002C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
CA2740004A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
CA2756222A1 (en) 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
US10894014B2 (en) 2015-06-18 2021-01-19 Estetra Sprl Orodispersible tablet containing Estetrol
MD3310346T2 (ro) 2015-06-18 2021-06-30 Estetra Sprl Comprimată orodispersabilă ce conține estetrol
PL3106148T3 (pl) 2015-06-18 2018-08-31 Mithra Pharmaceuticals S A Jednostka dawkowania ulegająca rozpadowi w jamie ustnej zawierająca składnik estetrolowy
EP3310333B1 (en) 2015-06-18 2020-04-29 Estetra SPRL Orodispersible dosage unit containing an estetrol component
SI3313408T1 (sl) * 2015-06-23 2024-04-30 Laboratorios Leon Farma Sa Kontraceptiv na osnovi drospirenona za pacientko s prekomerno težo
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
WO2018060501A2 (en) 2016-09-30 2018-04-05 Myovant Sciences Gmbh Methods of treating uterine fibroids and endometriosis
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
US12138270B2 (en) 2021-09-07 2024-11-12 Millicent Pharma Limited Contraceptive regimen including reduced level of estrogen

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244096A (en) 1988-04-22 1993-09-14 Stoner Fred L Preventive treatment kit against sexually transmitted disease
WO1993013801A1 (en) 1992-01-17 1993-07-22 The Procter & Gamble Company Treatment for atherosclerosis
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
IL127797A (en) 1996-07-26 2004-08-31 Wyeth Corp A one-step method of contraception and a kit containing a combination of progestin and estrogen
US6451778B1 (en) * 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US5842441A (en) 1996-08-26 1998-12-01 Pharmalett Denmark A/S Medicated and individualized treatment shampoo for dermatological disturbances of companion animals
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
DE122009000007I2 (de) 1999-08-31 2011-07-21 Bayer Schering Pharma Pharmazeutische kombination von ethinylestradiol und drospirenone als empfangnisverhutendes mittel.
CO5271709A1 (es) 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos
US6653298B2 (en) * 2000-01-14 2003-11-25 Sterix Limited Composition
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
IL145876A0 (en) 2000-10-17 2002-07-25 Pfizer Prod Inc Methods and kits for improving vascular health
US20020193356A1 (en) * 2001-05-23 2002-12-19 Van Beek Agatha Antonia Magdalena Means and method for hormonal contraception
US20030018018A1 (en) 2001-07-10 2003-01-23 Medical College Of Hampton Roads Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea
MY151322A (en) 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
US8501720B2 (en) 2004-07-30 2013-08-06 Bayer Pharma AG Method for treatment of dysmenorrhea

Similar Documents

Publication Publication Date Title
JP2015187157A5 (enExample)
JP2013018787A5 (enExample)
JP2018193377A5 (enExample)
JP2016147915A5 (enExample)
JP2015038149A5 (enExample)
JP2010180236A5 (enExample)
JP2013155188A5 (enExample)
JP2012193216A5 (enExample)
JP2015038135A5 (enExample)
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
JP2017506624A5 (enExample)
JP2016185995A5 (enExample)
JP2013529665A5 (enExample)
JP2016532516A5 (enExample)
JP2021509395A5 (enExample)
JP2017512194A5 (enExample)
JP2017507142A5 (enExample)
MX380070B (es) Una composición farmacéutica que comprende amlodipino, valsartán y rosuvastatina.
JP2016505050A5 (enExample)
JP2019507786A5 (enExample)
CN110520135A (zh) 维生素组合物在制备用于预防、治疗或延迟阿尔茨海默病的药物中的用途
JP2017061488A5 (enExample)
JP2019535830A5 (enExample)
JP2013047269A5 (enExample)
JP2017530142A5 (enExample)